To date, the cornerstone of MAFLD/MASH management has focused on lifestyle interventions that converge on weight loss through net negative energy balance, improved dietary quality and composition, increased physical activity (both aerobic and resistance), and reduced sedentary behavior
We have a lot to learn to understand why
Now, it is also FDA-approved to help with weight loss in adults with a BMI greater than or equal to 30 mg/kg alone or 27 mg/kg with at least one weight-related comorbidity such as insulin resistance, hypertension, high cholesterol, heart disease, and gout
Your initial consultation with our team involves a review of your medical background, weight statistics, and other critical data to ascertain your suitability for treatment at the Semaglutide Weight Loss clinic
Mol Psychiatry 28 , 564578 (2023)